JANUS HENDERSON GROUP PLC - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 93 filers reported holding CARDIFF ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q1 2022$4,320,000
-79.6%
1,742,123
-50.6%
0.00%
-77.8%
Q4 2021$21,170,000
-10.1%
3,523,012
-0.3%
0.01%
-10.0%
Q3 2021$23,541,000
+12.3%
3,533,381
+12.1%
0.01%
+11.1%
Q2 2021$20,954,000
-22.9%
3,151,167
+7.3%
0.01%
-25.0%
Q1 2021$27,187,000
-29.3%
2,937,182
+37.4%
0.01%
-33.3%
Q4 2020$38,434,000
+167.5%
2,137,671
+111.1%
0.02%
+157.1%
Q3 2020$14,368,0001,012,8180.01%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
ELKHORN PARTNERS LIMITED PARTNERSHIP 45,000$630.04%
FinDec Wealth Services, Inc. 16,000$22,2400.02%
DENVER WEALTH MANAGEMENT, INC. 18,235$25,3470.02%
Atom Investors LP 18,298$25,4340.01%
Laurion Capital Management LP 722,100$1,003,7190.01%
MAI Capital Management 224,749$312,4010.01%
Callan Capital, LLC 31,147$43,2940.01%
GSA CAPITAL PARTNERS LLP 25,975$360.00%
Tortoise Investment Management, LLC 15,000$20,8500.00%
America First Investment Advisors, LLC 4,000$5,5600.00%
View complete list of CARDIFF ONCOLOGY INC shareholders